GGrantIndex
← Search

TRIAL TO ACCESS SAFETY/IMMUNOGENICITY/PROTECTIVE EFFICACY OF INFLUENZA VACCINE

$592M01FY2000RRNIH

Vanderbilt University, Nashville TN

Investigators

Linked publications & trials

View original record on NIH RePORTER →